3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
27
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Smoking
1
Motor Activity
1
Depression
1
Breast Neoplasms
1
Anxiety Disorders
1
Alcohol Drinking
1
Interventions
Cisplatin
54
Cyclophosphamide
42
Fluorouracil
41
Oxaliplatin
36
Capecitabine
35
Docetaxel
34
Gemcitabine
32
Drug Therapy
32
Radiotherapy
31
Paclitaxel
25
Dexamethasone
23
Carboplatin
23
Leucovorin
21
Etoposide
17
Doxorubicin
17
Cytarabine
17
apatinib
16
Methotrexate
16
Magnetic Resonance Spectroscopy
14
Radiation
13
Epirubicin
13
Busulfan
13
Bevacizumab
13
Surgical Procedures, Operative
12
Neoadjuvant Therapy
12
Letrozole
12
Decitabine
12
Saline Solution
11
Irinotecan
11
venetoclax
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
OTHER
×
Mindfulness-Based Stress Reduction
×
Clear all
NCT00990977
2015-06-30
MICA
Danish Cancer Society
Phase 2/3
Completed
336 enrolled